Cholangiocarcinoma: Current Knowledge and New Developments - Wikidata - wikimedia - TriplyDB

Cholangiocarcinoma: Current Knowledge and New Developments

Cholangiocarcinoma: Current Knowledge and New Developments

http://www.wikidata.org/entity/Q28076098

about

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma.Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report.Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.[Precancerous and early stage cancer of the bile duct system].Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof.Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type Mirizzi Syndrome: Diagnosis and Management of a Challenging Biliary Disease Recurrent Cholangiocarcinoma in Pregnancy: A Case Report The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium

P2860

Q30398807-A1D64B6D-D042-4B00-8DEE-E84F709D0B3D Q33869560-95CC1452-9E4B-4D4F-8535-2512C5E3E3F8 Q41345470-B3739AC6-B59F-40E8-A769-1030496CEA52 Q41692447-0239C53A-4003-46B0-894B-4F7A2D892D53 Q42363911-643CBB6F-379A-4B5C-880F-AF5840FD3FA6 Q47550861-E3D324E8-2AB9-4CC5-A37B-055FAFFA7D94 Q47603972-CCD4E1A1-AFD6-4F53-AB2A-24D2EF062C2C Q49606237-03A1B574-A93A-4AC4-91A9-D35ADB63F267 Q52649647-659352FE-5E3A-4E08-8E46-7931750F3718 Q57111762-AE7B46FB-3A41-410D-B2A8-AC85702E786C Q57112061-60180E89-BAA6-4A02-8F60-D12CAE530243 Q58695617-D7F3E513-19F6-44BE-983C-4E491F66D8B4 Q59133892-19E1DA89-C448-448A-88C3-DC0CD6B856F5

P2860

Cholangiocarcinoma: Current Knowledge and New Developments

http://www.wikidata.org/entity/Q28076098

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cholangiocarcinoma: Current Knowledge and New Developments

@ast

Cholangiocarcinoma: Current Knowledge and New Developments

@en

Cholangiocarcinoma: Current Knowledge and New Developments

@nl

type

label

Cholangiocarcinoma: Current Knowledge and New Developments

@ast

Cholangiocarcinoma: Current Knowledge and New Developments

@en

Cholangiocarcinoma: Current Knowledge and New Developments

@nl

prefLabel

Cholangiocarcinoma: Current Knowledge and New Developments

@ast

Cholangiocarcinoma: Current Knowledge and New Developments

@en

Cholangiocarcinoma: Current Knowledge and New Developments

@nl

P1433

Q28076098-A8BB0426-F0CE-48E4-B043-1A09556FED40

P1476

Q28076098-E46FD7B9-572E-4C25-9048-BF8047D4E4D3

P2093

Q28076098-DF67EF53-210E-4DE6-8215-173B0958938F

P275

Q28076098-E58EF0B2-31F8-44E0-939F-442A756B2D8B

P2860

Q28076098-037E3A84-11A4-4C4F-8BC6-64DFD7BC5F54

Q28076098-05224A69-26B2-4FEC-B02E-467416051F44

Q28076098-0C2C40E9-A02D-432A-9059-2B8575EA9BF6

Q28076098-1A5C65FB-0C46-459F-99E5-75C2AE61846D

Q28076098-1F284E51-0E69-4EFA-935A-5123460CB815

Q28076098-255B0064-7FA9-49A1-B2A2-1257E06C36A2

Q28076098-32F0DF5A-28B6-427E-9E25-8CB508B277EF

Q28076098-359F5111-ED32-4D11-906B-5F0311DA5283

Q28076098-3BFE81AF-C4AB-4C0E-99E6-9DF42A0DF308

Q28076098-3CD8591D-FCCC-4D94-A33A-566AD149BB7B

P31

Q28076098-4B4B7E2F-727D-4BB4-9AC1-3A2835592880

Q28076098-CB577215-FCE9-42A1-865E-A41C9CFFF150

P356

Q28076098-10C1A21D-BA2C-400D-821A-62D02BA03CAB

P407

Q28076098-2EA129EE-169A-4C5F-9AA4-998B356D1039

P5008

Q28076098-D03BAC75-C1B1-458E-A151-38F3950BE0CE

P577

Q28076098-95F7E5C6-D992-4382-9783-EADED37BDD91

Q28076098-984D561B-01C1-458B-9247-3E9B28650E80

P698

Q28076098-268EFE3A-1B0A-49B5-9BFD-F313437600F2

P921

Q28076098-78E1EB58-E5A2-42DF-96EF-8E4B15815E1C

Q28076098-90CCB4DE-AE15-4108-BF1A-72BF803406C8

P932

Q28076098-1E2BC9FB-675A-4B5C-8D79-F6754F7AFA58

P356

P1433

P1476

Cholangiocarcinoma: Current Knowledge and New Developments

@en

P2093

Boris Blechacz

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma

The role of inflammation in cholestasis: clinical and basic aspects

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

P31

scholarly article

P356

10.5009/GNL15568

http://www.w3.org/2001/XMLSchema#string

P407

P5008

P577

2016-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27928095

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

bile duct neoplasm

P932

5221857

http://www.w3.org/2001/XMLSchema#string